BioAtla (BCAB) Change in Accured Expenses (2020 - 2026)

BioAtla's Change in Accured Expenses history runs 7 years deep, the most recent figure standing at $3.1 million for Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 45.18% year-over-year to $3.1 million; the TTM figure through Mar 2026 stood at $3.8 million (up 258.67% YoY), while the FY2025 annual figure was $2.8 million, up 120.83% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at $3.1 million, up from -$747000.0 in the prior quarter.
• The five-year high for Change in Accured Expenses was $8.3 million in Q2 2022, with the low at -$9.0 million in Q1 2024.
• The 5-year median for Change in Accured Expenses is $421000.0 (2025), against an average of $65117.6.
• The sharpest annual moves came in 2022 and 2023: Change in Accured Expenses plunged 2179.49% in 2022, then soared 229.51% in 2023.
• BioAtla's Change in Accured Expenses stood at -$735000.0 in 2022, then plunged by 886.26% to -$7.2 million in 2023, then soared by 56.17% to -$3.2 million in 2024, then surged by 76.49% to -$747000.0 in 2025, then soared by 510.84% to $3.1 million in 2026.
• Business Quant data shows BCAB's Change in Accured Expenses at $3.1 million in Q1 2026, -$747000.0 in Q4 2025, and $1.0 million in Q3 2025.